glp-1 approval FDA Approves First Generic Liraglutide for Weight Loss A diabetes drug. Then a

When to Contact Your Healthcare Provider About Back Pain Mild, temporary back soreness during semaglutide treatment is generally not cause for concern and typically resolves with hydration, stretching, and light activity

The First Triple Agonist for Antiobesity: Retatrutide (Cardiology in Review)

Storage at 4

One avenue of exploration involves investigating novel GLP-1 receptor agonists with enhanced properties, such as longer durations of action or improved targeting of specific receptors to optimize weight loss outcomes

Author contributions: Credit authorship contribution statement: Conceptualization of study, investigation, writing- original draft D.C.M